Archives
-
Deracoxib and Piroxicam in Canine Osteosarcoma
2026-09-01
This 2005 study compared deracoxib with piroxicam in three canine osteosarcoma cell lines and one fibroblast line, combining viability measurements with DNA-fragmentation analysis. Deracoxib produced concentration-dependent loss of osteosarcoma cell viability at lower concentrations than piroxicam while sparing fibroblasts within the tested range, but the study found no evidence that either drug caused apoptosis under its limited fragmentation-testing conditions.
-
S63845: MCL1 Inhibitor for Apoptosis Assays
2026-09-01
S63845 is a selective MCL1 inhibitor for dissecting mitochondrial apoptosis beyond simple viability measurements. This article shows how GET3-dependent MCL1 membrane targeting, cell-cycle state, and orthogonal BAX/BAK readouts can improve interpretation in hematological cancer research.
-
From E3-Ligase Mechanism to FLAG-Tagging Strategy
2026-08-31
A translational framework connecting the NEDD4L–PRMT5–AKT/mTOR metastasis mechanism with rigorous recombinant protein validation using the 3X (DYKDDDDK) Peptide and 3X FLAG peptide.
-
Hydroxyl-Radical Degradation of Dimetridazole
2026-08-31
This theoretical study maps how hydroxyl radicals transform Dimetridazole and ornidazole in water, combining reaction mechanisms, rate calculations, lifetime estimates, and toxicity prediction. Its central implication is that rapid chemical degradation does not necessarily mean immediate detoxification, because early transformation products may be more hazardous than the parent compounds.
-
Nurr1 Neurons and Rat Claustrum Development
2026-08-30
Fang, Wang, and Naumann mapped the prenatal emergence and birth-dating sequence of Nurr1-positive neurons across the rat claustrum, endopiriform regions, and lateral cortex. By combining EdU labeling with Nurr1 in situ hybridization, the study resolves distinct neurogenetic windows and spatial gradients that help refine developmental boundaries within this complex forebrain structure.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-08-29
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA to support PCR product contamination elimination and DNA-focused research. It is not intended for RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
-
Heparin Sodium as a Translational Nanovesicle Probe
2026-08-28
A mechanistic guide to using Heparin sodium as both an anticoagulation benchmark and an exploratory probe of heparan sulfate proteoglycan-dependent nanovesicle uptake in Sertoli-cell injury models.
-
LAG-3–TCR Proximity in T Cell Suppression
2026-08-28
A 2025 Cell study shows that LAG-3-mediated inhibition depends on spatial proximity to the T cell receptor, rather than MHC class II binding or CD4 association alone. The work identifies disruption of the CD3ε–Lck signaling complex and develops an Fc-attenuated LAG-3/TCR bispecific antibody that suppresses pathogenic CD4+ and CD8+ T cells in autoimmune models.
-
Perospirone: Receptor Logic Meets Vascular Insight
2026-08-27
Perospirone, also known as SM-9018 free base, offers a useful translational bridge between serotonergic and dopaminergic receptor biology and emerging vascular ion-channel pharmacology. This thought-leadership perspective outlines how researchers can use the compound to strengthen schizophrenia research, neuropsychiatric disorder models, and safety-oriented experimental design.
-
Sumatriptan Succinate: Assay Workflows
2026-08-27
Build more reproducible serotonergic signaling, inflammation, and metabolism assays with Sumatriptan Succinate, a practical 5-HT1 receptor agonist for mechanism-focused research. The key advantage is an integrated workflow that combines receptor pharmacology with isoform-aware metabolic analysis rather than assuming MAO A is the only clearance route.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-26
Use one transcript to distinguish mRNA uptake from productive protein expression in cell and animal studies. This workflow combines Cy5 tracking, luciferase quantification, and evidence-based optimization of delivery, timing, and treatment conditions.
-
PD0325901: Linking MEK Signals to Chromatin State
2026-08-26
Explore how PD0325901 can serve as a mechanistic perturbation tool for connecting MEK–ERK activity with cell-cycle control, apoptosis, and chromatin accessibility. This article pairs established pharmacology with the single-molecule nucleosome insights of IDLI to improve assay design and interpretation.
-
Phalloidin B7678: F-Actin Workflow Guide
2026-08-25
Phalloidin B7678 provides high-affinity binding and stabilization of filamentous actin for endpoint cytoskeleton visualization in fixed or permeabilized samples. It is not appropriate for live-cell imaging or experiments that require reversible actin remodeling because it can alter the native F-actin and G-actin equilibrium.
-
MOG (35-55) Peptide for EAE Research
2026-08-25
MOG (35-55) is a myelin oligodendrocyte glycoprotein peptide used to induce experimental autoimmune encephalomyelitis in preclinical multiple sclerosis research. Its defined handling range supports antigen-driven neuroinflammation assays, while recent EAE work links disease modulation to PARP7, STAT1/STAT2, and type I interferon signaling.
-
Bleomycin Sulfate: From DNA Damage to Fibrosis
2026-08-24
Bleomycin Sulfate is more than a DNA strand-break inducer: it is a controllable bridge between cancer biology, immune injury, and pulmonary fibrosis research. This article explains how to use the model to connect genomic damage with macrophage-specific STING signaling and improve translational assay design.